NOVARTIS AG-REG (NOT.DE) Stock Earnings & Estimates
Europe - Frankfurt Stock Exchange - FRA:NOT - CH0012005267 - Common Stock
118.24 EUR
-0.02 (-0.02%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 43.375B -1.36% | 46.66B 7.57% | 51.722B 10.85% | 56.573B 9.38% | 58.096B 2.69% | 60.501B 4.14% | 63.728B 5.33% | 66.79B 4.80% | 69.328B 3.80% | 74.245B 7.09% | 73.094B -1.55% | |
| EBITDA YoY % growth | 17.387B 1.82% | 20.919B 20.31% | 20.919B | 23.599B 12.81% | 23.863B 1.12% | 25.139B 5.35% | 30.91B 22.96% | 33.024B 6.84% | 32.184B -2.54% | 28.42B -11.70% | 26.503B -6.75% | |
| EBIT YoY % growth | 10.206B -6.91% | 12.642B 23.87% | 16.32B 29.09% | 21.305B 30.55% | 21.458B 0.72% | 22.808B 6.29% | 25.925B 13.67% | 27.523B 6.16% | 28.065B 1.97% | 28.614B 1.96% | 24.933B -12.86% | |
| Operating Margin | 23.53% | 27.09% | 31.55% | 37.66% | 36.94% | 37.70% | 40.68% | 41.21% | 40.48% | 38.54% | 34.11% | |
| EPS YoY % growth | 6.12 -2.70% | 6.90 12.75% | 7.81 13.19% | 9.12 16.78% | 9.33 2.32% | 10.02 7.37% | 11.17 11.46% | 12.21 9.35% | 12.45 1.98% | 11.63 -6.63% | 10.01 -13.95% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.99 0.33% | 2.33 2.29% | 2.31 -4.45% | 2.26 0.50% | 2.03 2.43% |
| Revenue Q2Q % growth | 14.105B 7.24% | 14.267B 7.81% | 14.477B 3.01% | 14.452B 3.90% | 14.414B 2.19% |
| EBITDA Q2Q % growth | 4.438B -56.18% | 5.487B -7.63% | 5.806B -23.25% | 5.692B -31.63% | 5.522B 24.43% |
| EBIT Q2Q % growth | 4.682B 15.35% | 5.48B 14.50% | 5.565B 7.95% | 5.569B 22.37% | 5.091B 8.74% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 2.25 9.22% | 2.30 | -0.05 | -2.10% |
| Q2 2025 Q2Q % growth | 2.42 22.84% | 2.41 | 0.01 | 0.61% |
| Q1 2025 Q2Q % growth | 2.28 26.67% | 2.14 | 0.14 | 6.59% |
| Q4 2024 Q2Q % growth | 1.98 29.41% | 1.87 | 0.11 | 6.06% |
| Q3 2024 Q2Q % growth | 2.06 12.57% | 1.99 | 0.07 | 3.78% |
| Q2 2024 Q2Q % growth | 1.97 7.65% | 1.91 | 0.06 | 3.24% |
| Q1 2024 Q2Q % growth | 1.80 5.26% | 1.71 | 0.09 | 5.40% |
| Q4 2023 Q2Q % growth | 1.53 0.66% | 1.65 | -0.12 | -7.44% |
| Q3 2023 Q2Q % growth | 1.83 15.82% | 1.76 | 0.07 | 3.88% |
| Q2 2023 Q2Q % growth | 1.83 17.31% | 1.73 | 0.10 | 5.73% |
| Q1 2023 Q2Q % growth | 1.71 17.12% | 1.56 | 0.15 | 9.32% |
| Q4 2022 Q2Q % growth | 1.52 8.57% | 1.43 | 0.09 | 6.28% |
| Q3 2022 Q2Q % growth | 1.58 -7.60% | 1.58 | 0.00 | -0.02% |
| Q2 2022 Q2Q % growth | 1.56 -6.02% | 1.53 | 0.03 | 2.08% |
| Q1 2022 Q2Q % growth | 1.46 -3.95% | 1.47 | -0.01 | -0.62% |
| Q4 2021 Q2Q % growth | 1.40 4.48% | 1.45 | -0.05 | -3.12% |
| Q3 2021 Q2Q % growth | 1.71 12.50% | 1.68 | 0.03 | 1.93% |
| Q2 2021 Q2Q % growth | 1.66 22.06% | 1.57 | 0.09 | 5.67% |
| Q1 2021 Q2Q % growth | 1.52 -2.56% | 1.59 | -0.07 | -4.32% |
| Q4 2020 Q2Q % growth | 1.34 | 1.40 | -0.06 | -4.21% |
| Q3 2020 Q2Q % growth | 1.52 | 1.48 | 0.04 | 2.60% |
| Q2 2020 Q2Q % growth | 1.36 | 1.35 | 0.01 | 0.78% |
| Q1 2020 Q2Q % growth | 1.56 | 1.42 | 0.14 | 9.89% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 13.909B 5.60% | 14.312B | -403M | -2.82% |
| Q2 2025 Q2Q % growth | 14.054B 9.18% | 14.465B | -411M | -2.84% |
| Q1 2025 Q2Q % growth | 13.233B 9.18% | 13.384B | -151M | -1.13% |
| Q4 2024 Q2Q % growth | 13.153B 11.69% | 13.051B | 102M | 0.78% |
| Q3 2024 Q2Q % growth | 13.172B 8.93% | 12.994B | 178M | 1.37% |
| Q2 2024 Q2Q % growth | 12.872B 9.60% | 12.61B | 262M | 2.08% |
| Q1 2024 Q2Q % growth | 12.12B 9.71% | 11.709B | 411M | 3.51% |
| Q4 2023 Q2Q % growth | 11.776B 8.24% | 11.996B | -220M | -1.83% |
| Q3 2023 Q2Q % growth | 12.092B 12.14% | 12.001B | 91M | 0.76% |
| Q2 2023 Q2Q % growth | 11.745B -45.91% | 13.518B | -1.773B | -13.12% |
| Q1 2023 Q2Q % growth | 11.047B -14.64% | 12.877B | -1.83B | -14.21% |
| Q4 2022 Q2Q % growth | 10.88B 135.55% | 13.285B | -2.405B | -18.10% |
| Q3 2022 Q2Q % growth | 10.783B -19.33% | 13.106B | -2.323B | -17.72% |
| Q2 2022 Q2Q % growth | 21.712B 63.32% | 13.109B | 8.603B | 65.63% |
| Q1 2022 Q2Q % growth | 1.95% | 12.942B | % | |
| Q4 2021 Q2Q % growth | 4.619B -64.55% | 13.616B | -8.997B | -66.08% |
| Q3 2021 Q2Q % growth | 13.367B 6.61% | 13.285B | 82M | 0.62% |
| Q2 2021 Q2Q % growth | 13.294B 14.39% | 12.773B | 521M | 4.08% |
| Q1 2021 Q2Q % growth | 12.694B -0.11% | 12.771B | -77M | -0.60% |
| Q4 2020 Q2Q % growth | 13.03B | 13.147B | -117M | -0.89% |
| Q3 2020 Q2Q % growth | 12.538B | 12.818B | -280M | -2.18% |
| Q2 2020 Q2Q % growth | 11.622B | 12.13B | -508M | -4.19% |
| Q1 2020 Q2Q % growth | 12.708B | 12.249B | 459M | 3.75% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.49% | 0.58% | -0.14% | 0.52% |
| Revenue | -0.01% | 0.73% | -0.05% | 0.38% |